Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors
Article Abstract:
The state Medicaid agencies was surveyed to determine whether prescription of cyclooxygenase-2 inhibitors (coxibs) required prior authorization and, if so, the criteria for authorization. It was found that the use of coxibs and spending on nonsteroidal antiinflammatory drugs (NSAIDs) varied widely by state and declined substantially after the implementation of prior-authorization programs.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
The pharmaceutical industry versus medicaid-limits on state initiatives to control prescription-drug costs
Article Abstract:
The management of health care costs and expenditure on prescription drugs are discussed. The features of Medicaid programs organized by some state initiatives for reducing expenditures on prescription drugs are presented.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Overall plan avoids compensation chaos as practices merge. Specialists carve out new ties with primary care doctors
- Abstracts: Using an early warning system in a medical assessment unit. Palliative care: Meeting the needs of dying patients
- Abstracts: Metformin and thiazolidinedione use in Medicare patients with heart failure. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure
- Abstracts: Defending professional independence: ACCME's proposed new guidelines for commercial support of CME. Separating Continuing Medical Education From Pharmaceutical Marketing
- Abstracts: The dilemma of Medicaid. Insuring all children - The new political imperative. Medicare and drug pricing